Thursday , April 9 2020
  • Loading stock data...

Home / Health / Pharmaceutical Industry Brings Cannabis Drug to FDA After Decades of U.S. Denying Value of Marijuana

Pharmaceutical Industry Brings Cannabis Drug to FDA After Decades of U.S. Denying Value of Marijuana

By Kate Sheridan

A prescription medication made from marijuana might be approved by the Food and Drug Administration this summer. The advance could be a huge step forward for people with epilepsy, which this drug treats. And it would signal a new—some would say long-delayed—embrace of cannabis-based medications in the U.S.

GW Pharmaceuticals, the company behind the drug, started the approval process with the FDA last year, and a study published this week offers more encouraging signs.

The medication under investigation is made of cannabidiol, or CBD. In a study published Wednesday in The Lancet, researchers gave either a brand name form of CBD called Epidiolex or a placebo to more than 170 people with Lennox-Gastaut syndrome, a rare, severe and difficult-to-treat form of epilepsy. Adding CBD to other anti-seizure medications cut down on the number of seizures a person experienced each month by 41 percent. By contrast, the placebo reduced the number by about 14 percent.

Read more at Newsweek

About admin

Check Also

Cannabis Consumers Want Hollywood To Abandon Marijuana Stereotypes

By Mike Adams If Hollywood plans to capitalize on the average cannabis consumer, a new …

Leave a Reply

Your email address will not be published. Required fields are marked *

CONTACT US
Thank You. We will contact you as soon as possible.
SUBSCRIBE TO OUR NEWSLETTER
* we never share your e-mail with third parties.